Understanding MK-677 in Research Context
MK-677 (Ibutamoren) is a non-peptide, orally bioavailable growth hormone secretagogue utilized exclusively in laboratory and preclinical investigations. It acts as a potent, selective agonist of the ghrelin receptor (GHSR-1a), mimicking the action of the endogenous hormone ghrelin to stimulate growth hormone release from the anterior pituitary without interacting with other receptor systems. In controlled research environments, MK-677 enables the study of pulsatile growth hormone secretion patterns, insulin-like growth factor‑1 (IGF‑1) upregulation, and associated metabolic cascades. Importantly, this compound is not approved for human or veterinary use and is supplied solely for basic scientific research under carefully regulated laboratory conditions.
The primary research value of MK-677 lies in its ability to sustain elevated growth hormone levels over extended experimental windows without the need for injection. This characteristic makes it a versatile tool in models of energy homeostasis, nutrient-utilization pathways, and skeletal muscle remodeling. Typical research designs involve in vitro receptor binding assays, ex vivo tissue cultures, and longitudinal in vivo studies using rodent models. All handling must be performed by qualified personnel in appropriate facilities, adhering to institutional biosafety and chemical hygiene protocols. The absence of any therapeutic claim binds every consignment that leaves a MK-677 manufacturer in China: the material is intended exclusively for research, analytical, or laboratory-scale synthesis purposes.
Chemical Properties and Applications
MK-677 is designated chemically as 2-amino-2-methyl-N-[(1R)-2-(1-methylsulfonylspiro[2H‑indole‑3,4′‑piperidine]-1′-yl)-2-oxo-1-(phenylmethyl)ethyl]propanamide, with a molecular formula of C27H36N4O5S and a molar mass of approximately 528.66 g·mol−1. The compound is a light yellow to white lyophilized powder that is freely soluble in dimethyl sulfoxide (DMSO) and ethanol, and sparingly soluble in water—characteristics that influence the choice of vehicle for in vitro and in vivo administration. Under recommended storage at −20 °C in a desiccated, light-protected environment, the anhydrous powder remains stable for at least two years when sourced from a manufacturer that provides lot‑specific stability data.
For reproducible experimental outcomes, researchers account for MK-677’s hygroscopic nature and its susceptibility to oxidation upon prolonged exposure to atmospheric moisture. Therefore, procurement from a supplier that packs the material under inert gas (argon or nitrogen) and provides moisture-proof, sealed vials is a critical quality marker. Common laboratory investigations include:
- Elucidation of the ghrelin–GHSR axis and its downstream effects on nutrient sensing.
- Examining age-related alterations in lean tissue maintenance using longitudinal rodent models.
- Profiling metabolic markers like IGF‑1, growth hormone, and cortisol in dose‑response paradigms.
- Assessing bone turnover markers in ovariectomized models to understand endocrine regulation.
All these applications are strictly limited to non‑clinical, non‑diagnostic settings. The material must be handled in accordance with the supplier’s safety data sheet (SDS) and all applicable institutional regulations.
Evaluating MK-677 Manufacturers in China
When selecting a MK-677 manufacturer in China, procurement officers and laboratory managers prioritize verifiable technical rigor and a demonstrable commitment to analytical transparency. The supplier landscape includes specialized fine‑chemical producers and peptide synthesis houses that have diversified into small‑molecule secretagogues. A dependable manufacturing partner distinguishes itself through several observable attributes:
- Routine submission of batches to third‑party, ISO/IEC 17025‑accredited laboratories for high‑performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis.
- Operation within facilities that follow Good Manufacturing Practice (GMP) principles for active pharmaceutical ingredients (APIs) intended for research use, even though no finished medicinal product claim is made.
- A documented history of exporting research‑grade chemicals to institutions in North America, Europe, and Asia‑Pacific, reflecting familiarity with varying international expectations.
Third‑party purity testing is non‑negotiable; a reliable manufacturer will not rely solely on in‑house quality control. Look for certificates that report purity ≥ 98 % as determined by HPLC at 210–220 nm, with complementary mass confirmation of the molecular ion [M+H]+ at m/z 529.3. GMP‑compliant synthesis environments reduce the risk of cross‑contamination with residual solvents (e.g., acetonitrile, methanol) and heavy metals, which are quantified and kept below ICH Q3C thresholds. Manufacturers that openly share a facility inspection history or hold active registrations with entities such as China’s National Medical Products Administration (NMPA) for chemical APIs provide an additional layer of confidence.
Quality Assurance Protocols
A rigorous quality assurance (QA) framework transforms a MK-677 manufacturer in China from a simple supplier into a strategic research partner. At the core of this framework is the Certificate of Analysis (CoA) that accompanies every lot. A credible CoA extends beyond a purity percentage and includes:
- HPLC chromatogram with integration parameters, column type, and retention time.
- Mass spectrum (ESI‑MS or HRMS) confirming molecular mass and isotopic distribution.
- Residual solvent analysis by gas chromatography (GC‑FID or GC‑MS).
- Water content by Karl Fischer titration (typical acceptance criterion ≤ 1.0 %).
- Elemental analysis or heavy metal reporting according to USP or equivalent.
Stability testing forms the second pillar. Progressive manufacturers conduct forced‑degradation studies under accelerated conditions (40 °C/75 % relative humidity) and real‑time monitoring at long‑term storage (−20 °C) to define a retest interval. The resulting data are shared in the form of a stability report, enabling researchers to plan experiments without concern about material degradation. Additionally, traceability is maintained from the starting raw materials (including the chiral intermediates used for the synthesis of the (R)-configured aminoamide moiety) through to the final filled and labeled container. Each batch record links raw material lot numbers, synthesis logs, purification steps, and QC results into a single, auditable file.
Compliance with International Research Standards
A reliable MK-677 manufacturer in China will proactively align its documentation with the import regulations of its customers’ countries. For European Economic Area members, the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation (EC) No 1907/2006 requires that imported substances be registered in volumes above 1 tonne per year. While individual research‑scale shipments often fall below that threshold, the manufacturer should be prepared to supply a tonnage‑band confirmation or arrange for the registration of the substance as an isolated intermediate if volumes increase. Compliance with the Classification, Labelling and Packaging (CLP) regulation (EC) No 1272/2008 ensures that the substance is correctly classified for physicochemical and health hazards, and that the associated hazard and precautionary statements appear on the label.
Beyond Europe, the manufacturer’s documentation package must support seamless customs clearance elsewhere. A typical export dossier for a research chemical includes:
- A comprehensive Sicherheitsdatenblatt (SDB) in the format prescribed by the destination country (e.g., ANSI Z400.1 for the United States, WHMIS 2015 for Canada).
- A Certificate of Origin stating the country of manufacture, often required for preferential tariff treatment or to satisfy trade‑control requirements.
- Packaging and labeling that uses the Globally Harmonized System (GHS) pictograms, signal words, and precautionary statements as adopted in the destination jurisdiction.
Manufacturers that invest in consultative support—helping resellers or end‑users navigate the interplay between the Toxic Substances Control Act (TSCA) in the United States and the requirement that the substance be used only for R&D—significantly reduce the administrative burden on purchasing organizations.
Supply Chain and Logistics for Export
The transport of MK-677 from a MK-677 manufacturer in China to overseas laboratories demands a logistics framework that preserves chemical integrity and meets all legal obligations. Unlike some thermolabile peptides that require continuous cold chain (−70 to −20 °C), MK-677 powder is stable under ambient conditions for the short transit times typical of express air freight. Nevertheless, meticulous packaging guards against physical damage and humidity ingress. Vials are individually sealed in low‑particulate, vacuum‑sealed foil pouches with desiccant, then cushioned inside outer cartons that conform to IATA Dangerous Goods Regulations if applicable—while MK-677 is not classified as dangerous goods in most jurisdictions, shippers often adopt a ‘goods of a non‑regulated nature’ protocol.
Lead times for standard research‑grade material range from 3 to 10 business days after confirmation of payment, depending on batch size and the amount of finishing work (lyophilization, aliquoting) required. Custom synthesis projects may extend to 3–6 weeks. Partners that maintain a stock program for high‑demand references can ship same‑day or next‑day, which is critical for time‑sensitive in vivo studies. Reliable logistics providers with a track record in chemical exports—such as FedEx, DHL, or UPS with their specialized healthcare divisions—are the preferred choice. These carriers offer advanced customs‑pre‑clearance systems and tracking visibility from the point of departure to final delivery.
Customs and Import Documentation
Smooth border clearance begins with accurate Harmonized System (HS) code classification. MK-677, a heterocyclic sulfonamide, is typically classified under Chapter 29 of the HS nomenclature—most commonly under heading 2935 (sulfonamides) with a more specific subheading such as 2935.90.9000 (or country‑specific variants). The manufacturer should provide a written classification rationale to support the consignee in responding to customs queries. The minimum documentation set required for a research‑chemical shipment includes:
- Commercial invoice clearly labeling the goods as “laboratory research chemical, not for human or veterinary use” and stating a nominal value.
- Packing list detailing the number of vials, net weight, and gross weight.
- Analysezertifikat (CoA) und Sicherheitsdatenblatt (SDB).
- Any additional certificates requested by the importing country, such as a GMO‑free statement or a batch manufacturing record extract.
Country‑specific import restrictions must be verified beforehand. For instance, some nations require a technical import license for any chemical listed on their controlled substance or precursor schedules, even if MK-677 is not scheduled. A proactive manufacturer will maintain a knowledge base of such requirements and may assist with non‑endorsable documents like product‑origin confirmations or end‑user declarations to facilitate release from customs holds.
Certification and Documentation Requirements
A complete documentation package serves as the primary instrument for building trust with a MK-677 manufacturer in China. Beyond the batch‑specific CoA and MSDS already discussed, buyers should expect to receive or be able to request the following certificates at any time:
- GMP Certificate or a corresponding third‑party audit report demonstrating that the production facility operates under recognized GMP guidelines for chemical APIs.
- Manufacturer License issued by the provincial or national regulatory authority, confirming the legal right to manufacture and export the substance.
- ISO 9001:2015 certificate for quality management systems, ensuring continuous improvement, corrective‑action tracking, and process documentation.
- Business registration license that verifies the manufacturer’s formal registration and scope of operations.
Transparency in documentation is a hallmark of a committed partner. For example, if a researcher requests the impurity profile—specifically, the identity and allowed limits of any synthetic by‑products (such as des‑methyl or chiral epimer analogs)—a reputable manufacturer will provide the raw data or a supplementary impurity CoA without insisting on a non‑disclosure agreement for such technical details. Batch‑specific spectral data (NMRs, IR spectra) can often be furnished upon request to confirm structural integrity, particularly for custom synthesis projects or when preparing reference standards for analytical method validation.
Establishing a Partnership with a Manufacturer
Engaging a MK-677 manufacturer in China as a long‑term collaborator goes beyond the purchase of a catalogue item. Direct communication channels—preferably a dedicated account manager with a background in organic chemistry or peptide synthesis—allow researchers to discuss custom specifications. Requests might include: gram‑scale synthesis of a specific anhydrous polymorph, preparation of a tritiated or stable‑isotope‑labeled analog for internal standard use, or lyophilization from a particular buffer system to facilitate downstream formulation in defined research vehicles.
Minimum order quantities (MOQs) vary widely; typical MOQs for standard MK-677 powder start at 10–25 grams, while custom synthesis may have higher thresholds depending on the complexity of the route. Scalability is essential for projects that move from pilot in vitro work to chronic in vivo feeding studies requiring multi‑gram quantities. A partner that can seamlessly transition from a laboratory‑scale batch (50–100 g) to a pilot‑plant campaign (1–10 kg) without altering the impurity fingerprint saves months of requalification. Confidentiality agreements that explicitly protect proprietary research directions, cell lines, or assay methodologies must be executed before any detailed discussion. The manufacturer should be willing to sign a bilateral nondisclosure agreement governed by a neutral jurisdiction, defining the treatment of shared intellectual property and limiting use of the researcher’s confidential information solely to the purpose of fulfilling the supply agreement.
Hinweis: Nur für Forschungszwecke: The information provided in this article pertains exclusively to the procurement and handling of MK-677 for in vitro laboratory research and preclinical animal studies. This compound is not intended for human or veterinary applications, nor for diagnostic use. All statements reflect standard industry documentation practices; they do not imply any suitability beyond controlled research environments.
Nur für Forschungszwecke. Nicht zur Anwendung am Menschen oder bei Tieren bestimmt.
